ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Clinical trials for ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat prostate cancer: experimental drug INV-9956 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called INV-9956 in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find a safe dose and see if the drug can shrink tumors or slow the disease. About 84 adult men will take p…
Matched conditions: ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New radioactive therapy targets tough prostate cancer
Disease control Recruiting nowThis early-stage study tests a new drug, 225Ac-PSMA-Trillium, in people with advanced prostate cancer that has spread and no longer responds to hormone therapy. The drug delivers radiation directly to cancer cells to damage and stop their growth. The main goals are to check safet…
Matched conditions: ADVANCED METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 22, 2026 13:54 UTC